A 3-month-old infant with ventricular septal defect (VSD) is admitted to the pediatric unit with signs of congestive heart failure. The infant is receiving digoxin 0.01 mg/kg/day divided into two doses. Which nursing assessment finding requires the most immediate intervention?

An apical pulse below 100 bpm in an infant indicates digoxin toxicity requiring immediate intervention. Other findings (HR 140, RR 50, weight gain 30g) are expected in CHF or require monitoring but are less urgent.

Clinical Context
A 3-month-old infant with a ventricular septal defect (VSD) is in congestive heart failure (CHF) and receiving digoxin. In this scenario, the nurse must recognize which assessment finding signals a potentially life-threatening complication of digoxin therapy requiring the most immediate intervention.

Correct Answer Analysis
The correct answer is 2. Apical pulse of 80 beats per minute.

Digoxin is a cardiac glycoside with a narrow therapeutic index, classified as a high-alert medication (HAM). The systematic review by Hernández-Gago et al. emphasizes that high-alert medications carry a heightened risk of causing significant patient harm when used in error, and their dosing requires extreme precision, especially in vulnerable populations like infants with altered physiology ^[1]. One of the earliest and most critical signs of digoxin toxicity in pediatric patients is bradycardia. The standard nursing procedure, and a critical safety checkpoint identified in HAM administration protocols, is to assess the apical pulse for a full minute before administering digoxin. For an infant, the generally accepted heart rate parameter for withholding digoxin and notifying the provider is an apical pulse less than 90-100 beats per minute. An apical pulse of 80 beats per minute is significantly below this threshold and indicates excessive vagal stimulation from digoxin, which can rapidly progress to more severe arrhythmias like second- or third-degree heart block. The physiological changes of CHF, such as reduced renal perfusion, can further decrease digoxin clearance, increasing the risk of toxicity even with a standard weight-based dose. This finding requires the nurse to immediately hold the medication and contact the prescriber, making it the highest priority intervention.

Distractor Analysis

1. Heart rate of 140 beats per minute
A heart rate of 140 beats per minute is within the normal range for a 3-month-old infant (typically 100-160 bpm while awake). While tachycardia can be a sign of worsening CHF, it is an expected compensatory mechanism in this scenario and does not represent an immediate contraindication to the prescribed therapy. The priority is the drug-related safety issue.

3. Respiratory rate of 50 breaths per minute
A respiratory rate of 50 breaths per minute is at the upper limit of normal for an infant (normal range 30-60 bpm). Tachypnea is a common finding in CHF due to pulmonary congestion. While it requires ongoing monitoring, it is an expected clinical manifestation of the admitting diagnosis, not an immediate, drug-related crisis.

4. Weight gain of 30 grams in 24 hours
A weight gain of 30 grams in 24 hours is a subtle finding. While it could indicate fluid retention associated with worsening CHF, it is not an acutely life-threatening sign. The nurse would document this and report it as part of the overall assessment, but it does not demand the same immediate, moment-to-moment intervention as a critically low heart rate prior to administering a high-alert negative chronotrope like digoxin.

Safety and Pharmacokinetic Considerations
The heightened risk with digoxin in this infant aligns with the core concerns raised in the systematic review on high-alert medications in pediatric patients. The review highlights that physiological changes, such as those from CHF (e.g., decreased renal perfusion and hepatic congestion), can significantly alter drug pharmacokinetics, specifically clearance, leading to drug accumulation even with correctly calculated weight-based doses ^[1]. For an infant with CHF, a reduced cardiac output can lower the glomerular filtration rate, directly impairing the renal excretion of digoxin. This creates a precarious situation where the therapeutic and toxic doses are dangerously close. The nursing assessment of the apical pulse is the most direct, real-time clinical indicator of this pharmacokinetic-to-pharmacodynamic relationship, serving as the final safety barrier before a potentially harmful dose is administered.